Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Diao Group Jiuhong Pharmaceutical is a key subsidiary of the Chengdu Diao Group, one of China's leading pharmaceutical conglomerates. The company focuses on the research, development, and large-scale production of both modern chemical drugs and traditional Chinese medicine (TCM) formulations. Its product portfolio is diverse, covering therapeutic areas such as cardiovascular health, anti-infectives, and digestive system disorders. Jiuhong Pharmaceutical operates advanced GMP-certified manufacturing facilities in Chengdu and contributes significantly to the group's reputation for high-quality cardiovascular treatments, including the flagship Di'ao Xinxuekang capsules. The company is recognized for integrating modern pharmacological standards with traditional therapeutic approaches to serve both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Diao Group Jiuhong Pharmaceutical.